Aerosol drug delivery: developments in device design and clinical use.
Dolovich
Myrna B
MB
Firestone Institute of Respiratory Health, St Joseph's Healthcare, Department of Medicine, McMaster University, Hamilton, ON, Canada. mdolovic@mcmaster.ca
Dhand
Rajiv
R
D000280:Administration, Inhalation; D000336:Aerosols / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage; D016503:Drug Delivery Systems; D004867:Equipment Design; D015316:Genetic Therapy / Q000379:methods; D006371:Helium / Q000008:administration & dosage; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D009330:Nebulizers and Vaporizers; D010100:Oxygen / Q000008:administration & dosage; D010316:Particle Size; D012121:Respiration, Artificial; D014612:Vaccines / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000008:administration & dosage
D000336:Aerosols; D007166:Immunosuppressive Agents; D014612:Vaccines; D014665:Vasodilator Agents; D006371:Helium; C038949:heliox; D016572:Cyclosporine; D016285:Iloprost; D010100:Oxygen